# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-020960
Filing Date
2023-04-27
Accepted
2023-04-27 16:21:27
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ny20008153x3_ars.pdf | ARS | 3579593
| Complete submission text file | 0001140361-23-020960.txt |  | 4930407

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39696 | Film No.: 23857320
SIC: 2836 Biological Products, (No Diagnostic Substances)